DNA methylation is an epigenetic mechanism critical for tissue development, cell specification and cellular function. Mammalian brains consist of millions to billions of neurons and glial cells that can be subdivided into many distinct types of cells. We hypothesize that brain methylomes are heterogeneously methylated across different types of cells and the transcription factors play key roles in brain methylome programming. To dissect brain methylome heterogeneity, in Chapter 2, we first focused on the identification of cell-subset specific methylated (CSM) loci which demonstrate bipolar DNA methylation pattern, i.e., hypermethylated in one cell subset but hypomethylated in others. With the genome-scale hairpin bisulfite sequencing approach, we demonstrated that the majority of CSM loci predicted likely resulted from the methylation differences among brain cells rather than from asymmetric DNA methylation between DNA double strands. Importantly, we found that putative CSM loci increased dramatically during early stages of brain development and were enriched for GWAS variants associated with neurological disorder-related diseases/traits. It suggests the important role of putative CSM loci during brain development, implying that dramatic changes in functions and complexities of the brain may be companied by a rapid change in epigenetic heterogeneity. To explore epigenetic regulatory mechanisms during brain development, as described in Chapter 3, we adopted unbiased data-driven approaches to re-analyze methylomes for human and mouse frontal cortices at different developmental stages. We predicted Egr1, a transcriptional factor with important roles in neuron maturation, synaptic plasticity, long-term memory formation and learning, plays an essential role in brain epigenetic programming. We performed EGR1 ChIP-seq and validated that thousands of EGR1 binding sites are with cell-type specific methylation patterns established during postnatal frontal cortex development. More specifically, the CpG dinucleotides within these EGR1 binding sites become hypomethylated in mature neurons but remain heavily methylated in glia. We further demonstrated that EGR1 recruits a DNA demethylase TET1 to remove the methylation marks at EGR1 binding sites and activate downstream genes. Also, we found that the frontal cortices from the knockout mice lacking Egr1 or Tet1 share strikingly similar profiles in both gene expression and DNA methylation. Collectively, the study in this dissertation reveals EGR1 programs the brain methylome together with TET1 during postnatal development. This study also provides new insights into how life experience and neuronal activity may shape the brain methylome. / Ph. D. / DNA methylation is a widespread epigenetic mark on DNA, serving as a “switch” to turn on or off gene expression. It plays essential roles in cellular functions, tissue development. Mammalian brains contain millions to billions of neurons and glial cells, which can be further divided into many different types of cells. We hypothesize that brain cells have different methylation profiles across the genome, and transcriptional factors play important roles in programming methylation in the mammalian brain genome. To study the diversity of methylation profiles across the genomes of different brain cells, in Chapter 2, we first focused on the identification of cell-subset specific methylated (CSM) genomic regions which show bipolar DNA methylation pattern, i.e., hypermethylated in one type of cell but hypomethylated in others. By applying a technique called the genome-scale hairpin bisulfite sequencing to mouse frontal cortices, we demonstrated that the majority of CSM genomic regions predicted likely resulted from the methylation differences among brain cells, rather than from methylation differences between DNA double strands. Surprisingly, we found that these predicted CSM genomic regions increased dramatically during early stages of brain development and were enriched for GWAS variants associated with neurological disorder-related diseases/traits. It suggests the importance of predicted CSM genomic regions, implying that dramatic changes in brain function and structure may be companied by a rapid change in DNA methylation diversity during brain development. To explore underlying epigenetic mechanisms during brain development, as described in Chapter 3, we re-analyzed methylomes for human and mouse frontal cortices at different developmental stages, and predicted Egr1, a transcriptional factor with important roles in neuron maturation, synaptic plasticity, long-term memory formation and learning, plays an essential role in brain methylome programming. We found thousands of EGR1 binding sites showed cell-type specific methylation patterns, and were established during postnatal frontal cortex development. More specifically, the methylation level of these EGR1 binding sites was low in mature neurons but pretty high in glial cells. We further demonstrated that EGR1 recruits a DNA demethylase TET1 to remove the methylation marks at EGR1 binding sites and activate downstream genes. Also, we found that the frontal cortices from the Egr1 knockout or Tet1 knockout mice show strikingly similar profiles in both gene expression and DNA methylation. Collectively, the study in this dissertation reveals EGR1 works together with TET1 to program the brain methylome during postnatal development. This study also provides new insights into how life experience and neuronal activity may shape the brain methylome.

La méthylation de l'ADN génomique est l'un des principaux mécanismes épigénétiques qui conduisent à des changements stables et héréditaires de l'expression des gènes sans que cela s’accompagne de la modification de la séquence d'ADN sous-jacente. Elle fait référence à l'addition d'un groupement méthyl sur le carbone 5 des cytosines (5meC). Ces dernières années, l’étude des mécanismes régulant la mise en place et le maintien de de cette méthylation est devenu un thème de recherche importante, en raison de son rôle essentiel dans la régulation du fonctionnement du génome des plantes et des mammifères. La distribution des 5meC sur l’ensemble du génome d’un organisme, encore appelé méthylome, peut être déterminée par différentes méthodes dont le séquençage de l’ADN génomique après traitement au bisulfite de sodium (WGBS ou méthyl C séq). Chez les végétaux, la méthylation de l’ADN peut se produire dans tous les contextes de séquence incluant les motifs symétriques CG et CHG et le contexte dissymétrique CHH (H pouvant être A, T ou C). En fonction du contexte de séquence, la méthylation des cytosines est mise en place et maintenue par trois types différents d'ADN méthyltransférase. [ ] Chez la plante-modèle Arabidopsis, la déméthylation active de l'ADN joue un rôle essentiel dans l'empreinte maternelle et la déméthylation l’ADN génomique lors du développement de l’albumen, mais elles ne semblent pas jouer de rôle essentiel pendant le développement de la plante chez cette espèce. La méthylation de l’ADN génomique peut aussi être perdue après la réplication de l’ADN, lorsque les mécanismes devant assurer son maintien ne sont pas actifs. On parle alors de déméthylation passive de l’ADN génomique. [ ] En conclusion, les observations présentées dans ce travail fournissent un cadre de travail permettant d’analyser les mécanismes moléculaires responsables de la déméthylation de l'ADN se produisant pendant la maturation des fruits de tomate. Ici, nous présentons une analyse complète des conséquences d’une réduction de l’expression du gène de SlDML2 sur le trancriptome et le métabolome des fruits, tout au long de leur développement. La corrélation entre les profils d’expression de gènes réalisées lors de ce travail ( variété WVA106) et les changements de la distribution de la méthylation de l’ADN telles que décrites chez la variété Ailsa craig montre qu’en plus d'un rôle général dans la régulation des gènes directement impliqués dans plusieurs voies métaboliques, plusieurs gènes codant pour des facteurs de transcription ainsi que des régulateurs épigénétiques sont également susceptibles d'être directement contrôlés par la méthylation de leur région promotrice. Cependant, nous ne pouvions pas établir une relation stricte entre la diminution de la méthylation de l'ADN et l'induction de l'expression des gènes, car de nombreux gènes présentant une diminution du niveau de méthylation de l'ADN dans leur région promotrice pendant la maturation des fruits sauvages correspondent à des gènes normalement réprimés. Ceci suggère que la méthylation active de l'ADN serait nécessaire à leur répression pendant le processus de maturation. Ainsi la relation entre la déméthylation de l'ADN et l'expression des gènes pourrait être plus complexe et ne se limiterait pas à la simple hypothèse de départ de ce travail: la déméthylation de l'ADN est nécessaire à l'expression de gènes induits au cours de la maturation. La déméthylation active de l'ADN pourrait également être nécessaire à la répression de gènes exprimés uniquement lors des phases précoces du développement des fruits et réprimés lors du murissement. / DNA methylation is one of the epigenetic mechanisms that lead to stable and heritable changes in gene expression without alteration on DNA sequence. DNA methylation refers to the addition of a methyl group to the fifth position of the cytosine ring. In recent years, DNA methylation is becoming more and more widely studied, because of its importance in mammals and plants. Methylated cytosines distribution can be determined across the genome at single-nucleotide resolution, that is methylome, using whole genome bisulfite-sequencing (BS-seq) approaches. [ ] Solanum lycopersicum (tomato) is an important agronomic crop and the main model to study the development and ripening process of climacteric fleshy fruit. Recent studies have now shown that the development and ripening of fleshy fruits relies on the establishment and maintenance of differential transcription patterns and complex regulatory pathways that involve both genetic and hormonal controls are operating at these developmental phases. However, it appears that a full understanding of fruit development and ripening will not be achieved based only on genetic models as suggested by recent studies, which showing an important decrease in global methylation level and demethylation at specific promoters during fruit ripening. [ ] In conclusion, the observations presented in this work provide a framework for analysis of the molecular mechanism of DNA demethylation during fruit ripening of tomato. Here, we provide a comprehensive analysis of the knock down SlDML2 on the trancriptome, metaoblom and DNA methylation in the promoter analysis. The large transcriptional reprogramming that occured in mutant during fruit ripeing was correlated alterations in DNA methylation. Here we highlight the central role of active DNA demethylation during tomato fruit ripening. In addition to a general role in the regulation of genes directly involved in several metabolic pathways, we also found that several transcription factors as well as epigenetic regulators are also likely under direct methylation control. However, we could not establish a district relationship between DNA reduction of DNA methylation and induction of gene expression, as not all DEGs containing a type-a DMRs (decreased DNA methylation during fruit ripening) do not correspond to genes normally induced in WT and repressed in transgenic plants. Some were corresponding to an opposite situation and in a few cases more complex methylation pattern (several DMRs) were also found. Indeed these conclusions are based on methylation analysis obtained in another variety. They might however reflect the situation of WVA106 fruits, although some variations are expectable when the methylome of DML RNAi fruits will be analyzed. Hence the relationship between DNA demethylation and gene expression might be more complex than expected, and not limited to the starting hypothesis of this work: DNA demethylation is an absolute requirement for the expression of critical ripening induced genes. This is indeed clearly in this study, but the analysis presented here also suggest that DNA demethylation might also be necessary for the repression of several genes as well. In addition, from the rencent study in Arabidopsis, ROS1 were found preferentially targets transposable elements (TEs) which are closer to protein coding genes and intergenic regions, which suggesting that ROS1 may prevent DNA methylation spreading from TEs to nearby genes. While in tomato, as our analysis, we found the methylation level of promoter of a number of genes was altered during fruit ripening, therefore, through methylome analysis, we will also get the preference of DNA methylation on TE, this analysis will give us idea that demethylation in fleshy fruit may has other distinct function as it is in Arabidopsis.

The efficacy of a novel carbohydrate extraction procedure was investigated with methylation analysis and alditol acetate method by Gas Chromatography-Mass Spectrometry. A published extraction procedure for β-glucans was compared to one developed in house. Both procedures gave a dominant glucose peak in the Gas chromatogram indicative of successful β-glucan isolation. Further linkage studies showed four linkage positions for β-glucans isolated with the published method; terminal, 1,3-linkage, 1,6-linkage and 1,3,6-linkage, while β-glucans isolated using the new method showed six linkage positions; terminal, 1,3-linkage, 1,6-linkage, 1,4-linkage, 1,2,3-linkage and 1,3,6-linkage. Diminishing β-glucan linkage peaks in the chromatogram for the published method indicated structure degradation. The results for mannan isolated with 50 mM base gave mannose as a dominant component compared to mannan isolated with 50 mM acid. Base extracted mannan also indicated a good yield of mannan in hyphal form of Candida albicans. This has not been reported with other published isolation methods.

No description available.

No description available.

No description available.

La méthylation de l’ADN et les modifications post-traductionnelles des histones sont desmodifications épigénétiques qui interviennent dans la régulation des éléments transposables(ET) chez de nombreuses espèces. La proportion des ET dans les génomes varie selon lesespèces considérées et pose la question des mécanismes de régulation de ces ET. Au sein del’espèce Drosophila simulans, les populations naturelles présentent un polymorphisme uniquedans le nombre de copies des ET, ce qui en fait un excellent modèle pour étudier cettequestion. L’étude de la méthylation d’ADN et des modifications post-traductionnelles deshistones associées au rétrotransposon à LTR tirant dans la lignée germinale des populationsnaturelles a permis de montrer l’influence d’une copie d’ET sur la structure de la chromatineau site d’insertion. Dans un second volet, nous avons cherché à caractériser la méthylation del’ADN chez la drosophile, chez laquelle la fonction est encore mal connue. Nous avons, pardes approches spécifiques et globales, mesuré l’abondance de cette marque épigénétique chezla drosophile. Nous concluons que les taux de méthylation de l’ADN sont très faibles maisvariables entre espèces. Notre travail n’a pas permis de mettre en évidence un rôle de laméthylation de l’ADN dans le contrôle des ET, toutefois, nous ne pouvons pas exclure cesystème de régulation. / Epigenetic modifications such as DNA methylation and post-translational histonemodifications are involved in transposable elements (TE) silencing in many species. Theirrelative abundance in genomes ask the question of differences in regulation mecanismbetween species. Within the Drosophila simulans species, natural populations exibits a uniquepolymorphism in TE copy number, providing a powerfull tool for the analysis of TEregulation in population from the same specie. We analyzed DNA methylation and posttranslationalhistone modifications associated with the LTR retrotransposon tirant in thegermline of natural populations and report the influence of this element on chromatinestructure. DNA methylation is a wide-conserved epigenetic modification involved in generegulation and TE silencing but its function in drosophila remains missunderstood. Usingdifferent methods, we determined the abundance of methylated cytosines in drosophila, andshowed that methylation level are low and variable between species. Our results show lowevidence for a TE regulation system involving DNA methylation but this cannot be so farexcluded.

Vertebrate genomes exhibit global methylation of cytosine residues where they occur in a cytosine-guanine dinucleotide (CpG) context and this epigenetic mark is generally thought to be repressive to transcription. Punctuating this pervasive DNA methylation landscape are short, contiguous regions of non-methylated DNA which are found at two thirds of mammalian gene promoters. These non-methylated regions exhibit CpG content close to expected levels as they escape the depletion of CpGs observed across the methylated fraction of the genome. The unique nucleotide properties of these CpG island (CGI) regions enable their identification by computational prediction in mammalian genomes. Owing to a lack of high-resolution genome-wide DNA methylation profiles in non-mammalian species, these CGI predictions have often been used as a proxy for non-methylated DNA in these organisms. In contrast to mammals, CGI predictions in cold-blooded vertebrates rarely coincide with gene promoters, leading to the belief that CGls are significantly divergent between vertebrate species, and that unique promoter-associated features may have been acquired during warmblooded vertebrate evolution. This thesis is primarily concerned with the location, establishment and biological function of non-methylated islands of DNA in vertebrate genomes. To experimentally determine genome-wide profiles of non-methylated DNA, a novel biochemical technique was established called biotinylated ZF-CxxC affinity purification (Bio-CAP), and development of this method is discussed in Chapter 3. Experimental analysis of non-methylated DNA profiles in this thesis initially addresses two main questions: (1) 'How does the non-methylated DNA landscape compare genome-wide for seven vertebrates considering distinct tissue types and developmental stages?' (2) 'How are vertebrate non-methylated regions of DNA defined and interpreted in the nuclear environment?' To address the first question, non-methylated DNA was profiled by Bio-CAP sequencing across the genomes of seven diverse vertebrate species, representing all major branch points of vertebrate evolution, and the results are discussed in Chapters 4 and S. Contrary to previously held dogma, experimentally determined nonmethylated islands of DNA (NMls) constitute an ancient epigenetic feature of vertebrate gene regulatory elements. However, despite having numerous high-resolution maps of vertebrate non-methylated DNA, the means by which NMls are identified and maintained in the nuclear environment remains poorly understood. To address the second question and identify features which determine the methylation state of DNA, exogenous DNA sequences were introduced into mouse embryonic stem (ES) c~.II~. Non-methylated DNA was profiled by Bio-CAP sequencing to investigate how different features, such as sequence-specific binding motifs, chromatin architecture and nucleotide composition of a given DNA sequence impact local DNA methylation patterns. Interestingly, the majority of exogenous promoters were appropriately non-methylated in mouse ES cells, germline and somatic cells suggesting that gene promoters have retained strong signals for the nonmethylated state across millions of years of evolution (discussed in Chapter 6). During mouse embryogenesis, genome-scale DNA demethylation and remethylation events occur to remodel the epigenetic landscape and loss of DNA methylation during this time leads to embryonic lethality. To investigate the biological function of non-methylated DNA, the third question addressed in this thesis is (3) 'What is the developmental importance of non-methylated islands of DNA during vertebrate embryogenesis?' To investigate this, members of the ZF-CxxC domain-containing family of chromatin modifiers were ablated in zebrafish embryos to perturb the chromatin landscape at NMls, and therefore interfere with their function during early development (Chapter 7). Early embryonic development and patterning was disrupted in knockdown embryos, suggesting that interpretation of non-methylated DNA and placement of chromatin modifications at NMls is essential for normal zebrafish embryogenesis. Together this work sheds light on the evolutionary origins of NMls, the mechanisms involved in the recognition and establishment of nonmethylated loci and provides an insight into the function of non-methylated DNA during early embryonic development.

L’hypothyroïdie congénitale par dysgénésie thyroïdienne (HCDT) est la condition endocrinienne néonatale la plus fréquemment rencontrée, avec une incidence d’un cas sur 4000 naissances vivantes. L’HCDT comprend toutes les anomalies du développement de la thyroïde. Parmi ces anomalies, le diagnostic le plus fréquent est l’ectopie thyroïdienne (~ 50% des cas). L’HCDT est fréquemment associée à un déficit sévère en hormones thyroïdiennes (hypothyroïdisme) pouvant conduire à un retard mental sévère si non traitée. Le programme de dépistage néonatal assure un diagnostic et un traitement précoce par hormones thyroïdiennes. Cependant, même avec un traitement précoce (en moyenne à 9 jours de vie), un retard de développement est toujours observé, surtout dans les cas les plus sévères (c.-à-d., perte de 10 points de QI). Bien que des cas familiaux soient rapportés (2% des cas), l’HCTD est essentiellement considérée comme une entité sporadique. De plus, plus de 92% des jumeaux monozygotiques sont discordants pour les dysgénésies thyroïdiennes et une prédominance féminine est rapportée (spécialement dans le cas d’ectopies thyroïdiennes), ces deux observations étant clairement incompatible avec un mode de transmission héréditaire mendélien. Il est donc cohérent de constater que des mutations germinales dans les facteurs de transcription thyroïdiens connus (NKX2.1, PAX8, FOXE1, and NKX2.5) ont été identifiées dans seulement 3% des cas sporadiques testés et furent, de plus, exclues lors d’analyse d’association dans certaines familles multiplex. Collectivement, ces données suggèrent que des mécanismes non mendéliens sont à l’origine de la majorité des cas de dysgénésie thyroïdienne. Parmi ces mécanismes, nous devons considérer des modifications épigénétiques, des mutations somatiques précoces (au stade du bourgeon thyroïdien lors des premiers stades de l’embryogenèse) ou des défauts développementaux stochastiques (c.-à-d., accumulation aléatoire de mutations germinales ou somatiques). Voilà pourquoi nous proposons un modèle «2 hits » combinant des mutations (épi)génétiques germinales et somatiques; ce modèle étant compatible avec le manque de transmission familial observé dans la majorité des cas d’HCDT. Dans cette thèse, nous avons déterminé si des variations somatiques (épi)génétiques sont associées à l’HCTD via une approche génomique et une approche gène candidat. Notre approche génomique a révélé que les thyroïdes ectopiques ont un profil d’expression différent des thyroïdes eutopiques (contrôles) et que ce profil d’expression est enrichi en gènes de la voie de signalisation Wnt. La voie des Wnt est cruciale pour la migration cellulaire et pour le développement de plusieurs organes dérivés de l’endoderme (p.ex. le pancréas). De plus, le rôle de la voie des Wnt dans la morphogénèse thyroïdienne est supporté par de récentes études sur le poisson-zèbre qui montrent des anomalies du développement thyroïdien lors de la perturbation de la voie des Wnt durant différentes étapes de l’organogénèse. Par conséquent, l’implication de la voie des Wnt dans l’étiologie de la dysgénésie thyroïdienne est biologiquement plausible. Une trouvaille inattendue de notre approche génomique fut de constater que la calcitonine était exprimée autant dans les thyroïdes ectopiques que dans les thyroïdes eutopiques (contrôles). Cette trouvaille remet en doute un dogme de l’embryologie de la thyroïde voulant que les cellules sécrétant la calcitonine (cellules C) proviennent exclusivement d’une structure extrathyroïdienne (les corps ultimobranchiaux) fusionnant seulement avec la thyroïde en fin de développement, lorsque la thyroïde a atteint son emplacement anatomique définitif. Notre approche gène candidat ne démontra aucune différence épigénétique (c.-à-d. de profil de méthylation) entre thyroïdes ectopiques et eutopiques, mais elle révéla la présence d’une région différentiellement méthylée (RDM) entre thyroïdes et leucocytes dans le promoteur de FOXE1. Le rôle crucial de FOXE1 dans la migration thyroïdienne lors du développement est connu et démontré dans le modèle murin. Nous avons démontré in vivo et in vitro que le statut de méthylation de cette RDM est corrélé avec l’expression de FOXE1 dans les tissus non tumoraux (c.-à-d., thyroïdes et leucocytes). Fort de ces résultats et sachant que les RDMs sont de potentiels points chauds de variations (épi)génétiques, nous avons lancé une étude cas-contrôles afin de déterminer si des variants génétiques rares localisés dans cette RDM sont associés à la dysgénésie thyroïdienne. Tous ces résultats générés lors de mes études doctorales ont dévoilé de nouveaux mécanismes pouvant expliquer la pathogenèse de la dysgénésie thyroïdienne, condition dont l’étiologie reste toujours une énigme. Ces résultats ouvrent aussi plusieurs champs de recherche prometteurs et vont aider à mieux comprendre tant les causes des dysgénésies thyroïdiennes que le développement embryonnaire normal de la thyroïde chez l’homme. / Congenital hypothyroidism from thyroid dysgenesis (CHTD) is the most common congenital endocrine disorder with an incidence of 1 in 4,000 live births. CHTD includes multiple abnormalities in thyroid gland development. Among them, the most common diagnostic category is thyroid ectopy (~ 50 % of cases). CHTD is frequently associated with a severe deficiency in thyroid hormones (hypothyroidism), which can lead to severe mental retardation if left untreated. The newborn biochemical screening program insures the rapid institution of thyroid hormone replacement therapy. Even with early treatment (on average at 9 d), subtle developmental delay is still be observed in severe cases (i.e., IQ loss of 10 points). Although there have been some reports of familial occurrence (in 2% of the cases), CHTD is mainly considered as a sporadic entity. Furthermore, monozygotic (MZ) twins show a high discordance rate (92%) for thyroid dysgenesis and female predominance is observed in thyroid dysgenesis (especially thyroid ectopy), these two observations being incompatible with simple Mendelian inheritance. In addition, germline mutations in the thyroid related transcription factors NKX2.1, PAX8, FOXE1, and NKX2.5 have been identified in only 3% of sporadic cases and linkage analysis has excluded these genes in some multiplex families with CHTD. Collectively, these data point to the involvement of non-Mendelian mechanisms in the etiology of the majority of cases of thyroid dysgenesis. Among the plausible mechanisms are epigenetic modifications, somatic mutations occurring in the thyroid bud early during embryogenesis, or stochastic developmental events. Hence, we proposed a two-hit model combining germline and somatic (epi)genetic variations that can explain the lack of clear familial transmission of CTHD. In this present thesis, we assessed the role of somatic (epi)genetic variations in the pathogenesis of thyroid dysgenesis via a genome-wide as well as a candidate gene approach. Our genome wide approach revealed that ectopic thyroids show a differential gene expression compared to that of normal thyroids, with enrichment for the Wnt signalling pathway. The Wnt signalling pathway is crucial for cell migration and for the development of several endoderm-derived organs (e.g., pancreas). Moreover, a role of Wnt signalling in thyroid organogenesis was further supported by recent zebrafish studies which showed thyroid abnormalities resulting from the disruption of the Wnt pathway during different steps of organogenesis. Thus, Wnt pathway involvement in the etiology of thyroid ectopy is biologically plausible. An unexpected finding of our genome-wide gene expression analysis of ectopic thyroids was that they express calcitonin similar to normally located (orthotopic) thyroids. Such a finding, although in contradiction with our current knowledge of the embryological development of the thyroid attributes C cell origins to extrathyroidal structures (ultimobrachial bodies) upon fusion with a fully-formed, normally situated gland. Using a candidate gene approach, we were unable to demonstrate any differences in the methylation profile between ectopic and eutopic thyroids, but nevertheless we documented the presence of a differentially methylated region (DMR) between thyroids and leukocytes in the promoter of FOXE1, a gene encoding the only thyroid related transcription factor known to play a crucial role in regulating the migration of the thyroid precursors during development as shown by animal studies. We demonstrated by in vivo and in vitro studies that the methylation status of this DMR is correlated with differential expression of FOXE1 in non-tumoral tissues (thyroids and leukocytes). Knowing that DMRs are hotspots for epi(genetic) variations, its screening among CTHD patients is justifiable in our search for a molecular basis of thyroid dysgenesis, currently underway in a case-control study. The results generated during my graduate studies represent unique and novel mechanisms underlying the pathogenesis of CHTD, the etiology of which is still an enigma. They also paved the way for many future studies that will aid in better understanding both the normal and pathogenic development of the thyroid gland.

Η υπέρταση είναι ένας από τους σημαντικότερους παράγοντες που αυξάνει τα καρδιαγγειακά επεισόδια τα οποία ευθύνονται περίπου για το ήμισυ των θανατηφόρων επεισοδίων στους ενήλικους. To σύστημα ρενίνης-αγγειοτασίνης-αλδοστερόνης (ΣΡΑΑ) διαδραματίζει καθοριστικό ρόλο στην παθοφυσιολογία των καρδιαγγειακών νόσων. Η αναστολή του ΣΡΑΑ σε παθολογικές καταστάσεις μπορεί να πραγματοποιηθεί με αναστολή του ενζύμου της ρενίνης ή παρεμπόδιση της σύνδεσης της ΑΙΙ με τους υποδοχείς ΑΤ1. Έχει διατυπωθεί η υπόθεση ότι τα αμφοτερικά μόρια για να αλληλεπιδράσουν με τον υποδοχέα θα πρέπει πρώτα να εισδύσουν σε κατάλληλη τοπογραφική θέση στις βιολογικές μεμβράνες και μετά με διάχυση να προσεγγίσουν το ενεργό κέντρο όπου όταν προσδεθούν με μία σειρά αντιδράσεων θα εξασκήσουν τη βιολογική τους δράση. Για την κατανόηση του ρόλου των μεμβρανών στο σύστημα ΣΡΑΑ μελετήθηκαν οι αλληλεπιδράσεις της αλισκιρένης (αναστολέας ρενίνης) και ολμεσαρτάνης (ανταγωνιστής αγγειοτασίνης ΙΙ) σε μοντέλα διπλοστιβάδων διπαλμιτικής φωσφατιδυλοχολίνης με ή χωρίς χοληστερόλη. Οι μελέτες διεξήχθησαν κάνοντας χρήση Πυρηνικού Μαγνητικού Συντονισμού (υγρής και στερεής κατάστασης), Διαφορικής Θερμιδομετρίας Σάρωσης, Φασματοσκοπίας Raman και Περίθλασης Ακτίνων-Χ. Σύγκριση των πειραματικών αποτελεσμάτων με άλλες σαρτάνες που μελετήθηκαν κάνοντας χρήση τις ίδιες τεχνικές απόδειξαν ότι όλα τα φάρμακα του ΣΡΑΑ εντοπίζονται στην ενδιάμεση φάση όπου εξασκούν διαφορετικές υδρόφιλες και λιπόφιλες αλληλεπιδράσεις. Επομένως το κάθε φάρμακο αποτυπώνει τη δική του σφραγίδα μέσα στις λιπιδικές διπλοστιβάδες. Αυτή η μοναδικότητα στις αλληλεπιδράσεις κάθε φαρμάκου με τις λιπιδικές διπλοστιβάδες ίσως να σχετίζεται και με τη μοναδικότητα του στο φαρμακευτικό του προφίλ. Ένα άλλο ενδιαφέρον αποτέλεσμα που προέκυψε από τις μελέτες είναι ότι η ολμεσαρτάνη σε μεθανολικό διάλυμα τόσο σε χαμηλή θερμοκρασία όσο και σε θερμοκρασία δωματίου δεν είναι σταθερή και μετατρέπεται στο αιθερικό της παράγωγο το οποίο ταυτοποιήθηκε φασματοσκοπικά. Στις ίδιες συνθήκες δεν παρατηρήθηκε εστεροποίηση. / Hypertension is one of the major risk factors responsible for the increase of half of the cardiovascular episodes in the adults. The system of Renin-Angiotensin-Aldosterone (RAAS) plays a determinative role in the pathophysiology of cardiovascular diseases. In a pathological state the aim is to block the generation of Angiotensin II through inhibition of rennin or angiotensin converting enzymes or its action on AT1 receptor. It has been hypothesized that amphiphilic molecules in order to exert their action on the receptor site, they have first to enter into the lipidic core of the lipid bilayers and then diffuse towards the active site. Thus, if this mechanism is applied, the lipidic part of the membrane bilayers appears to play an important role in the membrane action. To comprehend on the membrane:drug interactions we have studied the effects of olmesartan and aliskiren using dipalmitoylphosphatidylcholine bilayers with or without cholesterol. Various physical chemical methodologies such as liquid and solid state NMR , x-ray diffraction, Raman spectroscopy and Differential Scanning Calorimetry have been applied. The comparative results with other SARTANs showed that all drugs of the RAAS system act on the polar group and upper part of the alkyl chain, but exert different interactions. Thus, each drug is characterized by its own fingerprint in terms of its interactions and this may explain its unique pharmacological profile. Another, intriguing result derived from this thesis dissertation is the observation that olmesartan in methanolic solution is converted to its ether analogue. This isolated product was unambiguously structurally elucidated using a combination of LC-MS and 2D NMR spectroscopy.